Hôpital Necker-Enfants Malades, Department of Genetics
About Hôpital Necker-Enfants Malades, Department of Genetics
The Necker–Enfants Malades Hospital is a French teaching hospital in the 15th arrondissement of Paris. It is a hospital of the Assistance Publique – Hôpitaux de Paris group and is affiliated to the University of Paris Descartes.
There are 600 beds in Hôpital Necker-Enfants Malades, Department of Genetics.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hôpital Necker-Enfants Malades, Department of Genetics
During the past decade, Hôpital Necker-Enfants Malades, Department of Genetics conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
1995-12-01
2010-02-01
Completed
2,411
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
1999-05-01
2014-02-01
Completed
5,611
ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
1999-02-01
2008-09-22
Completed
22
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
2000-02-01
2019-11-01
Completed
2,130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome
2004-06-01
2012-02-01
Completed
806
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hôpital Necker-Enfants Malades, Department of Genetics
According to Clinical.Site data, the most researched conditions in "Hôpital Necker-Enfants Malades, Department of Genetics" are
"Fibrodysplasia Ossificans Progressiva" (4 trials). Many other conditions were trialed in "Hôpital Necker-Enfants Malades, Department of Genetics" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Necker-Enfants Malades, Department of Genetics
Most popular intervention types in "Hôpital Necker-Enfants Malades, Department of Genetics" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Palovarotene" (2 trials), "Palovarotene dose level 1" (1 trials), "Palovarotene dose level 2" (1 trials), "Palovarotene dose level 3" (1 trials) and "Palovarotene dose level 4" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Necker-Enfants Malades, Department of Genetics
The vast majority of trials in "Hôpital Necker-Enfants Malades, Department of Genetics" are
4 trials for "All" genders.
Clinical Trials Status at Hôpital Necker-Enfants Malades, Department of Genetics
Currently, there are NaN active trials in "Hôpital Necker-Enfants Malades, Department of Genetics".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hôpital Necker-Enfants Malades, Department of Genetics,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Necker-Enfants Malades, Department of Genetics, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".